<?xml version="1.0" encoding="UTF-8"?>
<p id="Par86">In hospitalized patients with COVID-19 several studies have noted prolongation of the QTc interval; however, interpreting this abnormality has been difficult because of the possibility of iatrogenicity from treatment with chloroquine or hydroxychloroquine [
 <xref ref-type="bibr" rid="CR95">95</xref>]. No studies have reported on power spectral analysis of heart rate variability, in either the time or frequency domains. There are numerous mechanisms by which SNS or SAS activation could precipitate cardiac arrhythmias [
 <xref ref-type="bibr" rid="CR50">50</xref>]. None of these has been explored specifically in COVID-19-related research.
</p>
